On August 26, Shenzhen, China's earliest and most successful special economic zone, celebrated its 45th birthday. Over 45 years of dramatic transformation, what was once a border agricultural county that "opened a window" for reform and opening-up has become one of China's most open cities with the strongest economic vitality. On this innovative land, Bgi Genomics Co.,Ltd. upholds its original mission of "genomic technologies benefiting mankind," continuously iterating, upgrading, innovating, and empowering. The company drives the development of human life science industries through technological innovation and continues to empower public health with technological strength, achieving mutual development with the Shenzhen Special Economic Zone and growing together.
Bgi Genomics Co.,Ltd. stated that Shenzhen is at the forefront of reform and opening-up, and the innovative soil here is the core reason why BGI established itself and took root in Shenzhen. Shenzhen's openness, innovation, and inclusiveness have allowed BGI to develop and grow freely. Among the four dimensions of Shenzhen's spirit - "daring to venture and experiment, openness and inclusiveness, pragmatism and respect for law, and pursuit of excellence" - the "pursuit of excellence" has had the most profound impact on BGI's values and decision-making.
**Innovation Soil is the Core Reason for BGI's Deep Roots in Shenzhen**
After 45 years of development, Shenzhen has achieved transformation from a processing and manufacturing base to a technology industry innovation center and established a strong foundation in internet and information industries. To some extent, BGI belongs to the "new Shenzhen residents."
BGI was established in 1999. In April 2007, BGI Life Science Research Institute (formerly Shenzhen BGI Genomics Research Institute) was established, marking the beginning of BGI's "Shenzhen time." Bgi Genomics Co.,Ltd. stated that Shenzhen is at the forefront of reform and opening-up, and the innovative soil here is the core reason why BGI established itself and took root in Shenzhen.
BGI's development to this point is inseparable from its own efforts and government support. In the early days, municipal government staff would come to the company to work on-site, helping enterprises solve problems. During the company's early development stage, there were also tax and fee reductions. Additionally, some municipal government leaders dared to innovate and be pioneers.
For example, when BGI previously conducted non-invasive prenatal genetic testing, this advanced technology had not been clinically applied anywhere in the world, yet Shenzhen issued official documents allowing the company to pilot this technology, which was very rare.
As a frontier city actively responding to the Belt and Road Initiative, Shenzhen has continuously expanded cooperation areas and deepened cooperation with Belt and Road partner countries and regions over the years. This unique "Shenzhen energy" has been not only an important springboard for BGI to "go global" but has also helped the company achieve a leap from being a "technology exporter" to a standard-setter for Belt and Road health cooperation through continuous institutional innovation and industrial ecosystem cultivation.
In recent years, to further promote the application of genetic technology in overseas countries, Bgi Genomics Co.,Ltd. has leveraged its rich experience in precision medical testing and public health disease control, actively promoting Chinese technology, Chinese experience, and Chinese standards to the world. The company is committed to improving local medical and health service levels through technological empowerment and experience sharing, helping build a more comprehensive health industry ecosystem and contributing "Chinese strength" to global health cooperation.
Charm, vitality, momentum, and innovation power vividly summarize Shenzhen's most important characteristics. Over 45 years, Shenzhen has consistently made great efforts to enhance the carrying capacity of talent platforms. By the end of 2019, Shenzhen had 2,260 various innovation carriers including national, provincial, and municipal key laboratories, engineering laboratories, engineering (technology) research centers, and enterprise technology centers, attracting batches of top global talent teams.
Bgi Genomics Co.,Ltd. also stated that Shenzhen's multicultural atmosphere and talent policies have helped it build a global team, effectively supporting the achievement of globalization strategic goals and injecting lasting momentum into the company's sustainable development.
It is understood that through more than 20 years of talent accumulation, scientific research accumulation, and industrial precipitation, Bgi Genomics Co.,Ltd. has built a marketing service network covering more than 100 countries and regions globally, as well as all provinces, autonomous regions, and municipalities in China. The company has become one of the few technology companies covering the entire industry chain and all application fields in this sector. Based on its advanced technology, complete configuration, and leading-scale multi-omics output platform, it has become a world-class scientific and technological service provider and precision medical service operator.
**Genomic Technologies Benefiting Mankind, Full Commitment to Practicing Original Mission**
Over the past 20-plus years, BGI has gained fame for three things: first, participating in the Chinese portion of the Human Genome Project (1% project); second, deciphering the complete genome sequence of the SARS virus and successfully developing SARS diagnostic kits; third, using genetic technology to help maintain public health security. Today, BGI has become a leading global genomics R&D institution. This is just a glimpse of Bgi Genomics Co.,Ltd.'s full commitment to practicing its original mission.
As a technology innovation-driven genetic technology company, Bgi Genomics Co.,Ltd. deeply recognizes that only by continuously improving its scientific and technological innovation R&D system and establishing a sound long-term mechanism for R&D investment can it forge core competitiveness through innovation.
Over the years, Bgi Genomics Co.,Ltd. has maintained high-proportion investments in upstream experimental technologies and information technologies for molecular detection, as well as application areas such as reproductive health, tumor prevention and control, and infectious disease prevention and control, achieving a series of important patent results.
In the future, Bgi Genomics Co.,Ltd. will continue to lead new technologies, expand new fields, explore new models, and create new achievements, fully committing to practicing its original mission.
First, accelerate the global layout of core businesses, forming a new development pattern of joint breakthroughs in domestic and international markets; second, based on the technological advantages of domestic autonomous sequencing platforms and the scale effects of large-sample testing, continuously expand gene health screening applications to public welfare projects, supporting global public health development with multi-omics autonomous core technological strength; third, comprehensively promote the integrated innovation of artificial intelligence large models with multi-omics data, transforming from production-type services to intelligent services, making new contributions to achieving precision health management and precision medicine.
Bgi Genomics Co.,Ltd. also mentioned that the company will accelerate the rapid transformation of R&D to clinical applications, continuously aiming to become a global leader covering the entire industry chain in precision medicine and public health fields; accelerate transformation and upgrading to a data-value-oriented enterprise, developing disease prevention and control and health management products based on the entire population, entire lifecycle, and all-round approach.
Standing at the new starting point of the 45th anniversary of the Shenzhen Special Economic Zone, this city that has always led with a "daring to venture and experiment" attitude is continuously advancing toward becoming a higher-level innovative city; and Bgi Genomics Co.,Ltd., which has grown alongside Shenzhen, will continue to use the original mission of "genomic technologies benefiting mankind" as its compass and the innovative confidence and industrial ecosystem endowed by Shenzhen as its sail, committed to becoming a global leader in the genomics field.
The mutual development between Bgi Genomics Co.,Ltd. and Shenzhen has long become a vivid footnote of the resonance between urban innovation vitality and corporate technological responsibility.
Comments